Related Experiment Video

Updated: Jun 25, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature

Adviye Ergul1, Weiguo Li, Mostafa M Elgebaly

  • 1Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA. aergul@mail.mcg.edu

Vascular Pharmacology
|March 5, 2009
PubMed

Insights

Hyperglycemia in acute ischemic stroke (AIS) patients worsens brain damage and impacts outcomes. Better understanding of neuronal and vascular protection strategies is needed for these patients.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Endocrinology

Background:

  • Acute ischemic stroke (AIS) involves artery occlusion, leading to neuronal and vascular damage.
  • Current AIS treatments are limited, highlighting the need for improved therapeutic targets.
  • Admission hyperglycemia affects up to 40% of AIS patients, complicating stroke outcomes.

Purpose of the Study:

  • To review the impact of diabetes and acute hyperglycemia on experimental stroke models.
  • To emphasize the effects on cerebrovasculature structure and function.
  • To discuss the clinical relevance of these findings.

Main Methods:

  • Literature review of experimental stroke studies.
  • Focus on studies investigating hyperglycemia's effects.
  • Analysis of cerebrovasculature structure and function in models.

Main Results:

  • Hyperglycemia exacerbates vascular and neuronal damage in experimental stroke.
  • Specific impacts on cerebrovasculature structure and function are detailed.
  • Findings suggest hyperglycemia compromises protective mechanisms.

Conclusions:

  • Hyperglycemia significantly worsens ischemic injury and stroke outcomes.
  • Defining targets for neuronal and vascular protection in hyperglycemic AIS is crucial.
  • Further research is needed to translate findings into clinical practice.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.